Massachusetts Alzheimer's Disease Research Center
马萨诸塞州阿尔茨海默病研究中心
基本信息
- 批准号:10511260
- 负责人:
- 金额:$ 5.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-15 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:18 year oldAlzheimer&aposs DiseaseAutopsyAutoradiographyAwardBiochemicalBiological AssayDiagnosisDigestionDrug or chemical Tissue DistributionEquipmentFreezingFrozen SectionsFundingGenerationsHistologicIn Situ HybridizationLasersLigandsMassachusettsMicroscopyMicrotomyMissionModelingMolecular ConformationNamesParaffinPeptide HydrolasesPositron-Emission TomographyPreparationProceduresProtocols documentationPublishingResearchResearch PersonnelSamplingServicesSliceSumSurfaceTechniquesTemperatureThickThinnessTissue BanksTissuescryostatexperimental studyin situ sequencinglaser capture microdissectionneuropathologyprotein aggregationreceptorrepairedtau Proteinstissue preparation
项目摘要
Project summary:
The awarded project is the Massachusetts Alzheimer Disease Research Center. A key,
mandated component of this Center is a Neuropathology Core, whose mission is to provide
autopsy diagnoses and provide tissue to investigators to further the overall mission of
understanding Alzheimer’s and related illnesses. Specific tissue preparations vary according to
the scientific project. Broadly, tissue is either fixed and embedded in paraffin blocks for
histological analyses, or snap frozen and stored at -80 degrees C. If frozen, the tissue can be
distributed en block for homogenization and biochemical analyses or cut into thin sections on
the order of 10 microns thickness using a specialized piece of equipment, a cryostat, that can
maintain the tissue in its frozen state while shaving the sections from the surface. These thin
frozen sections are ideal for experiments such as autoradiography of PET ligands, in situ
hybridization, specific immunostaining protocols, conformation specific assays including
protease digestions, laser capture microdissection, and newer assays such as in situ sequencing.
Although Center investigators are among the leaders in these approaches (eg. our Center was
the first to publish autoradiography of the current generation of tau PET ligands), and have
several active funded protocols in place using the other named techniques, we have been
unable to fulfill requests for cryostat prepared tissues since our cryostat is unable to maintain
freezing temperatures, and is unable to be repaired.
We have had, for many years, access to cryostats for the preparation of frozen sections of
banked tissue for distribution to investigators. These were a Leica CM 1900-6-1 and a Lecia CM
1900-3-1 cryostat; both are more than 18 years old, are no longer functional, and can no longer
be serviced or repaired. We therefore cannot prepare samples for the advanced studies noted
above including laser capture microscopy, in situ hybridization, in situ sequencing,
receptor/protein aggregate autoradiography. We have chosen the Leica CM 3050, which is the
current model of this equipment, to replace the broken and out of date cryostat.
In sum, we request funds to replace a critical piece of equipment for our Neuropathology core
of the ADRC. We appreciate your considering this request.
项目总结:
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRADLEY T. HYMAN其他文献
BRADLEY T. HYMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRADLEY T. HYMAN', 18)}}的其他基金
Discovery and development of apoE4 correctors for the treatment of Alzheimer's disease
发现和开发用于治疗阿尔茨海默病的 apoE4 校正剂
- 批准号:
10901029 - 财政年份:2023
- 资助金额:
$ 5.04万 - 项目类别:
MGH Diseases of Aging Pathway Via Stimulating Access to Research in Residency (MGH DAP StARR)
通过刺激住院医师研究参与 MGH 衰老途径疾病 (MGH DAP StARR)
- 批准号:
10592226 - 财政年份:2023
- 资助金额:
$ 5.04万 - 项目类别:
Multi-omic Brain Cell Atlas of Alzheimer's Disease Progression
阿尔茨海默病进展的多组学脑细胞图谱
- 批准号:
10461533 - 财政年份:2021
- 资助金额:
$ 5.04万 - 项目类别:
LRP1-tau interactions and Alzheimer Disease
LRP1-tau 相互作用与阿尔茨海默病
- 批准号:
10274154 - 财政年份:2021
- 资助金额:
$ 5.04万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center
马萨诸塞州阿尔茨海默病研究中心
- 批准号:
10332246 - 财政年份:2019
- 资助金额:
$ 5.04万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center
马萨诸塞州阿尔茨海默病研究中心
- 批准号:
9914193 - 财政年份:2019
- 资助金额:
$ 5.04万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center
马萨诸塞州阿尔茨海默病研究中心
- 批准号:
10378606 - 财政年份:2019
- 资助金额:
$ 5.04万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center
马萨诸塞州阿尔茨海默病研究中心
- 批准号:
10620661 - 财政年份:2019
- 资助金额:
$ 5.04万 - 项目类别:
Massachusetts Alzheimer's Disease Research Center P30 Diversity Supplement Gaona
马萨诸塞州阿尔茨海默病研究中心 P30 多样性补充剂高纳
- 批准号:
10522320 - 财政年份:2019
- 资助金额:
$ 5.04万 - 项目类别: